NCT07255833

Brief Summary

The primary objective of this retrospective study is to determine the impact of hyponatremia on quantitative measurements and characteristics of the ECG. Secondary objectives comprise qualitative ECG features during hyponatremia, such as lead type, rhythm, etc.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
250

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2022

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2022

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2025

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

September 22, 2025

Completed
2 months until next milestone

First Posted

Study publicly available on registry

December 1, 2025

Completed
Last Updated

December 1, 2025

Status Verified

November 1, 2025

Enrollment Period

2.6 years

First QC Date

September 22, 2025

Last Update Submit

November 20, 2025

Conditions

Keywords

hyponatremiaECGarrhythmiascardiacconduction

Outcome Measures

Primary Outcomes (1)

  • Comparison of quantitative (numeric) ECG features during and after resolution of hyponatremia.

    The primary aim is to determine the influence of hyponatremia on numeric ECG features of cardiac conduction (i.e., heart rate \[beats per minute, bpm\], RR interval \[milliseconds, ms\], PQ interval \[ms\], QRS duration \[ms\], (corrected) QT duration \[ms\], T-Wave \[millimeters, mm\], changes in ST segment, including ST elevations \[mm\] (STEMI mimics), ST depressions \[mm\]) in a large cohort of patients in the emergency department (ED). It is also to determine in a before-after comparison whether these features changed after correction of profound hyponatremia.

    at baseline and up to 1 year

Secondary Outcomes (2)

  • Comparison of qualitative ECG features during and after resolution of hyponatremia.

    at baseline and up to 1 year

  • Detection of hyponatremia on the basis of ECG changes.

    at baseline

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with profound hyponatremia presenting to the emergency department

You may qualify if:

  • Adult patients ≥18 years of the Emergency Department of the University Hospital of Cologne/Germany
  • Plasma sodium ≤125 mmol/L in the admission blood sample and ≥ 130 mEq/L in a subsequent sample obtained during inpatient care.
  • lead-ECG on admission and a second ECG during inpatient care after resolution of profound hyponatremia.

You may not qualify if:

  • Lack of follow-up sodium analyses within the first 24 hours after admission
  • initial blood glucose \>300 mg/dL
  • Moderate or severe hypokalemia (potassium level \< 3 mmol/L)
  • Moderate or severe hyperkalemia (potassium level \> 6 mmol/L)
  • Pacemaker dependency with ventricular pacing
  • Relevant structural heart disease
  • Severe ischemic cardiomyopathy with an EF \< 35%
  • Untreated severe aortic valve stenosis
  • Dilated cardiomyopathy (DCM)
  • Hypertrophic cardiomyopathy (HCM)
  • Arrhythmogenic right ventricular cardiomyopathy (ARVC)
  • Infiltrative cardiomyopathy
  • Ion channel disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Cologne

Cologne, 50937, Germany

Location

MeSH Terms

Conditions

HyponatremiaArrhythmias, Cardiac

Condition Hierarchy (Ancestors)

Water-Electrolyte ImbalanceMetabolic DiseasesNutritional and Metabolic DiseasesHeart DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Volker Burst, MD, Prof

    University Hospital Cologne

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof. Dr. med

Study Record Dates

First Submitted

September 22, 2025

First Posted

December 1, 2025

Study Start

June 1, 2022

Primary Completion

January 1, 2025

Study Completion

January 1, 2025

Last Updated

December 1, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will share

Data base will be shared upon request

Locations